menu search

Jasper Therapeutics Reports Second Quarter 2023 Financial Results and Provides a Business Update

Jasper Therapeutics Reports Second Quarter 2023 Financial Results and Provides a Business Update
First Patient Dosed in Phase 1 trial of Briquilimab in Lower-Risk Myelodysplastic Syndrome Strengthened the Board of Directors and Management Team with Multiple Appointments REDWOOD CITY, Calif., Aug. 11, 2023 (GLOBE NEWSWIRE) — Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a biotechnology company focused on development of briquilimab, a novel antibody therapy targeting c-Kit (CD117) to […] The post Jasper Therapeutics Reports Second Quarter 2023 Financial Results and Provides a Business Up... Read More
Posted: Aug 11 2023, 20:05
Author Name: forextv
Views: 102275

Search within

Pages Search Results: